{
    "Trade/Device Name(s)": [
        "Atlas One Step hCG Urine Pregnancy Test (Strip)",
        "Atlas One Step hCG Urine Pregnancy Test (Cassette)",
        "Atlas One Step hCG Urine Pregnancy Test (Midstream)"
    ],
    "Submitter Information": "Atlas Link Technology Co., Ltd.",
    "510(k) Number": "K203246",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071930"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "October 30, 2020",
    "Summary Letter Received Date": "November 9, 2020",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Immunochromatographic technology"
    ],
    "Methodologies": [
        "Qualitative visually-read immunoassay"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Midstream"
    ],
    "Document Summary": "FDA 510(k) summary for Atlas One Step hCG Urine Pregnancy Test in strip, cassette, and midstream formats for early pregnancy detection",
    "Indications for Use Summary": "Visually-read, lateral flow immunoassay for qualitative detection of human chorionic gonadotropin (hCG) in urine to aid early detection of pregnancy; for over-the-counter single use only, confirmation required by clinical examination",
    "fda_folder": "Clinical Chemistry"
}